Pabulenol

Overview

Pabulenol is a linear furanocoumarin derivative with anti-proliferative, cytotoxic and anti-platelet aggregation activities. Pabulenol inhibits the proliferation of lymphoma cells and platelet aggregation. Pabulenol can be used in relevant studies on T-cell lymphoma, hypertension and thrombotic diseases such as atherosclerosis.

Application

Products | Products > Disease Areas > Hypertension | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Chronic Disease and Inflammation | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Atherosclerosis and Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis

Product Information

• Catalog No.: HY-N9353
• CAS No.: 33889-70-2
• Molecular Formula: C16H14O5
• Molecular Weight: 286.28
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source